Cytology is the study of cells using a microscope.
Certain head and neck cancers that are positive for high-risk types of human papillomavirus (HPV) have a better prognosis and may need less aggressive treatment.
Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug.
A new paper in the Journal of the National Cancer Institute finds that testing for cervical cancer using HPV testing in addition to the Pap smear is unlikely to detect cancer cases that wouldn't be found using HPV testing alone.
The vaccine that protects against cancer-causing types of human papillomavirus (HPV) also prevents an uncommon but incurable childhood respiratory disease, according to a new study published in The Journal of Infectious Diseases.
Every year there are around 400 new cases of cervical cancer and a total of approximately 800 cancers associated with HPV (human papilloma virus). Two measures could reverse this trend: the nonavalent HPV vaccination co-developed at MedUni Vienna's Department of Obstetrics and Gynecology under the supervision of Elmar Joura and HPV screening by means of smear tests as secondary prevention.
Scientists have devised a simple test for an earlier and more accurate warning of returning bladder cancer than existing methods, according to research published in the British Journal of Cancer today (Friday).
Women who receive human papillomavirus testing, in addition to a pap smear, receive a faster, more complete diagnosis of possible cervical precancer, according to a study of over 450,000 women by Queen Mary University of London and the University of New Mexico Comprehensive Cancer Center.
Appalachia -- stretching from the southern tier of New York state to northern Alabama, Mississippi and Georgia -- has long experienced deep economic distress and deprivation, and the gamut of accompanying social problems.
Calcium carbonate, or CaCO3, comprises more than 4% of the earth's crust. Its most common natural forms are chalk, limestone, and marble, produced by the sedimentation of the shells of small fossilized snails, shellfish, and coral over millions of years.
Cervical cancer is often thought of as a disease that primarily affects young women. Because of this, many older women fail to keep up with appropriate screening as they age.
To support healthcare and scientific research groups with high quality cytological cell samples, the National Clinical Cytology Biobank at the Karolinska Institute in Stockholm (Sweden) has invested in 2D coded sample storage tubes and sample handling equipment from Micronic to provide traceable, high integrity storage of its valuable gynaecological cell samples.
Pancreatic cancer has the lowest survival rate among all major cancers, largely because physicians lack diagnostic tools to detect the disease in its early, treatable stages.
Zilico Ltd – a developer of a pioneering cervical cancer diagnostic system - has been selected by the IFC, a member of the World Bank Group, to be part of a unique program across India.
After years of trying, biologists have succeeded in creating an extremely bright red fluorescent protein in the lab.
A pioneering diagnostic system that is having a significant impact on the changing clinical pathway for cervical cancer will be on display at MEDICA 2016 by multi-award winning company, Zilico Ltd.
The American Society of Clinical Oncology today issued a new global guideline on screening for cervical cancer, one of the leading causes of cancer related death among women worldwide.
Veracyte, Inc.today announced new data suggesting the potential to enhance the performance of the Afirma Gene Expression Classifier in thyroid cancer diagnosis by combining the test's proven RNA expression-based capabilities with gene variant and fusion information – all on a single, robust RNA sequencing platform.
Olympus announces the launch of its new Microscopy web store, a full-featured e-commerce platform that makes it simple for customers to find the products they want.
Interpace Diagnostics Group, a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for better patient diagnosis and management, reported today that the Company has launched a new version of their AccuCEA™ product called "Insights" for Gastroenterologists who focus on diagnosing and treating pancreatic cancer.
Leptomeningeal metastases (LM), a devastating complication and predictor of poor survival in lung cancer patients, was found to be more prevalent in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations.